Share Email Print
cover

Proceedings Paper

Development of an in-vivo model for the study of photodynamic therapy and anti-angiogenic treatments
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

An in vivo model has been developed for the study (PDT) and anti-angiogenic treatments. Significant damage to the vasculature of the chick chorioallantoic membrane (CAM) was observed immediately following PDT with 5-aminolevulinic acid (ALA). Multicell human glioma spheriods were placed on the CAM at day five of embryonic development, however, neovascularization was not observed.

Paper Details

Date Published: 13 June 2003
PDF: 6 pages
Proc. SPIE 4952, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XII, (13 June 2003); doi: 10.1117/12.474104
Show Author Affiliations
Steen J. Madsen, Univ. of Nevada/Las Vegas (United States)
Chung-Ho Sun, Beckman Laser Institute and Medical Clinic (United States)
Beckman Laser Institute and Medical Clinic (United States)
Bruce J. Tromberg, Beckman Laser Institute and Medical Clinic (United States)
Beckman Laser Institute and Medical Clinic (United States)
Henry Hirschberg, Rikshospitalet (Norway)


Published in SPIE Proceedings Vol. 4952:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XII
David Kessel, Editor(s)

© SPIE. Terms of Use
Back to Top